Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2

Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19) in late 2019, hundreds of millions of people have been infected worldwide. There have been unprecedented efforts in acquiring effective vaccines to confer p...

Descripción completa

Detalles Bibliográficos
Autores principales: Salleh, Mohd Zulkifli, Norazmi, Mohd Nor, Deris, Zakuan Zainy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917804/
https://www.ncbi.nlm.nih.gov/pubmed/35287350
http://dx.doi.org/10.7717/peerj.13083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917804/
https://www.ncbi.nlm.nih.gov/pubmed/35287350
http://dx.doi.org/10.7717/peerj.13083

Ejemplares similares